NAFLD/NASH in patients with type 2 diabetes and related treatment options
Crossref DOI link: https://doi.org/10.1007/s40618-017-0799-3
Published Online: 2017-11-30
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Radaelli, M. G.
Martucci, F.
Perra, S.
Accornero, S.
Castoldi, G.
Lattuada, G.
Manzoni, G.
Perseghin, G.
License valid from 2017-11-30